Antibody tests for identification of current and past infection with SARS‐CoV‐2
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
How nanophotonic label-free biosensors can contribute to rapid and massive diagnostics of respiratory virus infections: COVID-19 case
The global sanitary crisis caused by the emergence of the respiratory virus SARS-CoV-2
and the COVID-19 outbreak has revealed the urgent need for rapid, accurate, and affordable …
and the COVID-19 outbreak has revealed the urgent need for rapid, accurate, and affordable …
Four-month clinical status of a cohort of patients after hospitalization for COVID-19
Importance Little is known about long-term sequelae of COVID-19. Objective To describe the
consequences at 4 months in patients hospitalized for COVID-19. Design, Setting, and …
consequences at 4 months in patients hospitalized for COVID-19. Design, Setting, and …
Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: serologic testing (September 2020)
Background The availability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) serologic testing has rapidly increased. Current assays use a variety of technologies …
2) serologic testing has rapidly increased. Current assays use a variety of technologies …
Nanodiagnostics to face SARS-CoV-2 and future pandemics: From an idea to the market and beyond
The COVID-19 pandemic made clear how our society requires quickly available tools to
address emerging healthcare issues. Diagnostic assays and devices are used every day to …
address emerging healthcare issues. Diagnostic assays and devices are used every day to …
Development and efficacy of lateral flow point-of-care testing devices for rapid and mass COVID-19 diagnosis by the detections of SARS-CoV-2 antigen and anti …
WY Hsieh, CH Lin, TC Lin, CH Lin, HF Chang, CH Tsai… - Diagnostics, 2021 - mdpi.com
The COVID-19 pandemic is an ongoing global pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2020–2021. COVID-19 is becoming …
respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2020–2021. COVID-19 is becoming …
Recent progress on rapid diagnosis of COVID-19 by point-of-care testing platforms
YN Tang, D Jiang, X Wang, Y Liu, D Wei - Chinese Chemical Letters, 2024 - Elsevier
The outbreak of COVID-19 has drawn great attention around the world. SARS-CoV-2 is a
highly infectious virus with occult transmission by many mutations and a long incubation …
highly infectious virus with occult transmission by many mutations and a long incubation …
COVID-19 antibody detecting rapid diagnostic tests show high cross-reactivity when challenged with pre-pandemic malaria, schistosomiasis and dengue samples
COVID-19 Antibody Detecting Rapid Diagnostic Tests (COVID-19 Ab RDTs) are the
preferred tool for SARS-CoV-2 seroprevalence studies, particularly in low-and middle …
preferred tool for SARS-CoV-2 seroprevalence studies, particularly in low-and middle …
A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19
NA Makoah, T Tipih, MM Litabe, M Brink… - Future …, 2022 - Taylor & Francis
Aim: The aim of this study was to investigate the utility of serological tests for the diagnosis of
COVID-19 during the first week of symptom onset in patients confirmed with the real-time RT …
COVID-19 during the first week of symptom onset in patients confirmed with the real-time RT …
SARS-CoV-2 tests: bridging the gap between laboratory sensors and clinical applications
This review covers emerging biosensors for SARS-CoV-2 detection together with a review of
the biochemical and clinical assays that are in use in hospitals and clinical laboratories. We …
the biochemical and clinical assays that are in use in hospitals and clinical laboratories. We …